GlaiveOptix
Shreveport, Louisiana, United States
About GlaiveOptix
GlaiveOptix is on a mission to provide sight to patients with end stage macular diseases utilizing proprietary nanotechnology. The company's main product, the GlaiveOptix Lens will see the integration of existing and proven technology into a miniature implantable device.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Dec 2023)
- Website: glaiveoptix.com
Industries & Categories
Health Care
Social Profiles
Canonical: https://fsome.com/organization/glaiveoptix-2476436 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.